ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2099

Incidence and Prevalence of Osteoarthritis in the United States Compared to Global Trends: Insights from the Global Burden of Disease Study (1990–2021)

Khadija Mohib1, Rameez Qasim2, Nicolas Barnechea Alvarado1, ZAUHA FAWAD MEMON3 and Muhammad Asjad Saleem4, 1Kirk Kerkorian School of Medicine at UNLV, Las Vegas, NV, 2Allama Iqbal Medical College Lahore, Lahore, Pakistan, 3Peoples University of Medical and Health Sciences for Women, Tando Allahyar, Sindh, Pakistan, 4Indus Hospital Karachi, Karachi

Meeting: ACR Convergence 2025

Keywords: Demographics, Osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (2079–2105) Osteoarthritis – Clinical Poster II

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Osteoarthritis (OA) is the most prevalent musculoskeletal condition, predominantly affecting individuals over the age of 55. According to the World Health Organization (WHO), OA has a global prevalence of 7.6%, with women comprising approximately 60% of cases. This study evaluates the global and U.S. trends in osteoarthritis incidence and prevalence from 1990 to 2021 using data from the Global Burden of Disease (GBD) study, highlighting the evolving burden on aging populations.

Methods: Data from the 2021 GBD database were analyzed to assess age-standardized incidence and prevalence rates of OA per 1,000,000 individuals aged 55 years and older. Trends from 1990 to 2021 were examined using the Annual Average Percentage Change (AAPC), with 95% confidence intervals (CIs) and p-values reported to determine statistical significance. Annual Percent Change (APC) was calculated across selected time intervals to capture fluctuations in trend patterns.

Results: Incidence: Globally, the incidence of OA increased significantly over the 31-year period, with an overall I-AAPC of 0.28% (95% CI: 0.26–0.30, p < 0.000001). Incidence rose by 0.286% in females and 0.28% in males, indicating similar upward trends across sexes. The global I-APC remained relatively stable, with no major deviations.In the United States, the I-AAPC was slightly lower at 0.20% (95% CI: 0.12–0.29, p < 0.000001). Males showed a lower rate of increase (0.16%) compared to females (0.28%), aligning closely with global female trends. However, APC varied significantly across intervals:1990–1995: Increase of 0.78% per year (95% CI: 0.49–0.94, p = 0.000002)1995–2005: Decline of -1.24% (95% CI: -1.32 to -1.15, p < 0.000001)2005–2009: Sharp increase of 1.84% (95% CI: 1.38–2.29, p < 0.000001)Prevalence: The global prevalence of OA also rose steadily, with a P-AAPC of 0.277% (95% CI: 0.26–0.27, p < 0.000001). Prevalence increased similarly among both males (0.28%) and females (0.29%). The most significant rise occurred between 2006–2009 with a P-APC of 0.69% (95% CI: 0.58–0.80, p < 0.000001), while the smallest change occurred between 2015–2018 (0.05%; 95% CI: -0.05 to 0.15, p = 0.315).In the United States, the P-AAPC was 0.1737% (95% CI: 0.0912–0.2563, p = 0.000037). Males showed a lower rate (0.14%) compared to females (0.24%). While overall prevalence increased, notable declines occurred:1995–1999: -1.46% (95% CI: -1.83 to -1.09, p < 0.000001)1999–2005: -0.89% The most significant rise occurred from 2005–2009, with a P-APC of 1.99%.

Conclusion: Between 1990 and 2021, both incidence and prevalence of osteoarthritis have increased among individuals aged 55 and older, in both the United States and globally. Despite some temporal fluctuations, the overall trend is upward, especially among women. These findings emphasize the growing burden of OA on aging populations and highlight the need for public health strategies focused on prevention, early diagnosis, and long-term management of osteoarthritis to reduce disability and healthcare costs associated with this chronic condition.

Supporting image 1

Supporting image 2


Disclosures: K. Mohib: None; R. Qasim: None; N. Barnechea Alvarado: None; Z. MEMON: None; M. Saleem: None.

To cite this abstract in AMA style:

Mohib K, Qasim R, Barnechea Alvarado N, MEMON Z, Saleem M. Incidence and Prevalence of Osteoarthritis in the United States Compared to Global Trends: Insights from the Global Burden of Disease Study (1990–2021) [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/incidence-and-prevalence-of-osteoarthritis-in-the-united-states-compared-to-global-trends-insights-from-the-global-burden-of-disease-study-1990-2021/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/incidence-and-prevalence-of-osteoarthritis-in-the-united-states-compared-to-global-trends-insights-from-the-global-burden-of-disease-study-1990-2021/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology